A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice

Clinical and Vaccine Immunology

Volumn 16, Issue 9, 2009, Pages 1344-1351

  Skerry, Ciaran M ^a   Cassidy, Joseph P ^b   English, Karen ^a   Feunou Feunou, Pascal ^c,d   Locht, Camille ^c,d   Mahon, Bernard P ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c INSTITUT PASTEUR DE LILLE   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN G2A; INTERLEUKIN 5; LIVE VACCINE; PERTUSSIS VACCINE; STREPTOMYCIN;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BORDETELLA PERTUSSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG SAFETY; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOGLOBULIN PRODUCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; TH1 CELL;

ADMINISTRATION, INHALATION; AEROSOLS; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; BORDETELLA INFECTIONS; BORDETELLA PERTUSSIS; COLONY COUNT, MICROBIAL; IMMUNOGLOBULIN G; INFLAMMATION; INTERFERON-GAMMA; LUNG; MICE; MICE, KNOCKOUT; PERTUSSIS VACCINE; RECEPTORS, INTERFERON; SURVIVAL ANALYSIS;

EID: 69849108924     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00082-09     Document Type: Article

References (45)

1. Adamson, P. C., T. C. Wu, B. D. Meade, M. Rubin, C. R. Manclark, and P. A. Pizzo. 1989. Pertussis in a previously immunized child with human immunodeficiency virus infection. J. Pediatr. 115:589-592. (Pubitemid 19248837)
2. Ausiello, C. M., R. Lande, F. Urbani, A. la Sala, P. Stefanelli, S. Salmaso, P. Mastrantonio, and A. Cassone. 1999. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect. Immun. 67:4064-4071.
3. Barbic, J., M. Leef, D. Burns, and R. Shahin. 1997. Role of gamma interferon in natural clearance of Bordetella pertussis infection. Infect. Immun. 65:4904-4908.
4. Barnard, A., B. P. Mahon, J. Watkins, K. Redhead, and K. H. Mills. 1996. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 87:372-380.
5. Berkowitz, D. M., R. I. Bechara, and L. L. Wolfenden. 2007. An unusual cause of cough and dyspnea in an immunocompromised patient. Chest 131:1599-1602. (Pubitemid 46762375)
6. Byrne, P., P. McGuirk. S. Todryk, and K. H. Mills. 2004. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur. J. Immunol. 34:2579-2588.
7. Cahill, E. S., D. T. O'Hagan, L. Illum, A. Barnard, K. H. G. Mills, and K. Redhead. 1995. Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles. Vaccine 13:455-462.
8. Cherry, J. D. 1992. Pertussis: the trials and tribulations of old and new pertussis vaccines. Vaccine 10:1033-1038.
9. Cohn, S. E., K. L. Knorr, P. H. Gilligan, M. L. Smiley, and D. J. Weber. 1993. Pertussis is rare in human immunodeficiency virus disease. Am. Rev. Respir. Dis. 147:411-413.
10. Colebunders, R., C. Vael, K. Blot, J. Van Meerbeeck, J. Van den Ende, and M. Ieven. 1994. Bordetella pertussis as a cause of chronic respiratory infection in an AIDS patient. Eur. J. Clin. Microbiol. Infect. Dis. 13:313-315.
11. Crowcroft, N. S., and R. G. Pebody. 2006. Recent developments in pertussis. Lancet 367:1926-1936.
12. Doebbeling, B., M. L. Feilmeier, and L. A. Herwaldt. 1990. Pertussis in an adult man infected with the human immunodeficiency virus. J. Infect. Dis. 161:1296-1298.
13. Englund, J. A., M. D. Decker, K. M. Edwards, M. E. Pichichero, M. C. Steinhoff, and E. L. Anderson. 1994. Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study. Pediatrics 93:37-43. (Pubitemid 24012126)
14. Ennis, D. P., J. Cassidy, and B. P. Mahon. 2005. Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model. Clin. Diagn. Lab. Immunol. 12:409-417.
15. Ennis, D. P., J. Cassidy, and B. P. Mahon. 2005. Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma. Immunol. Lett. 97:91-100.
16. Ennis, D. P., J. Cassidy, and B. P. Mahon. 2004. Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin. Exp. Allergy 34:1488-1497.
17. Finkelman, F., I. Katona, T. Mosmann, and R. Coffman. 1988. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J. Immunol. 140:1022-1027. (Pubitemid 18088561)
18. Finkelman, F. D., J. Holmes, I. M. Katona, J. F. Urban, M. P. Beckmann, L. S. Park, K. A. Schooley, R. L. Coffman, T. R. Mosmann, and W. E. Paul. 1990. Lymphokine control of in vivo immunoglobulin isotype selection. Annu. Rev. Immunol. 8:303-333.
19. Forsyth, K. D., C.-H. Wirsing von Konig, T. Tan, J. Caro, and S. Plotkin. 2007. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 25:2634-2642.
20. Grant, C. C., R. Roberts, R. Scragg, J. Stewart, D. Lennon, D. Kivell, R. Ford, and R. Menzies. 2003. Delayed immunisation and risk of pertussis in infants: unmatched case-control study. BMJ 326:852-853. (Pubitemid 36461417)
21. Janda, W. M., E. Santos, J. Stevens, D. Celig, L. Terrile, and P. C. Schreckenberger. 1994. Unexpected isolation of Bordetella pertussis from a blood culture. J. Clin. Microbiol. 32:2851-2853.
22. Kendrick, P. L., G. Eldering, M. K. Dixon, and J. Misner. 1947. Mouse protection tests in the study of pertussis vaccine: a comparative series using the intracerebral route for challenge. Am. J. Public Health Nations Health 37:803-810.
23. Khelef, N., C. M. Bachelet, B. B. Vargaftig, and N. Guiso. 1994. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins. Infect. Immun. 62:2893-2900.
24. Lewis, D., A. Larsen, and C. Wilson. 1986. Reduced interferon-gamma mRNA levels in human neonates. Evidence for an intrinsic T cell deficiency independent of other genes involved in T cell activation. J. Exp. Med. 163:1018-1023.
25. Mahon, B. P. 2001. The rational design of vaccine adjuvants for mucosal and neonatal immunization. Curr. Med. Chem. 8:1057-1075.
26. Mahon, B. P., M. T. Brady, and K. H. G. Mills. 2000. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J. Infect. Dis. 181:2087-2091.
27. Mahon, B. P., B. J. Sheahan, F. Griffin, G. Murphy, and K. H. G. Mills. 1997. Atypical disease after Bordetella pertussis respiratory infection of mice with targeted disruptions of interferon-gamma receptor or immunoglobulin μ chain genes. J. Exp. Med. 186:1843-1851.
28. Marchant, A., T. Goethebuer, M. Ota, I. Wolfe, S. Ceesay, D. De Grote, T. Corrah, S. Bennett, J. Wheeler, K. Huygen, P. Aaby, W. McAdam, and M. Newport. 1999. Newborns develop a Th1-type response to Mycobacterium bovis Bacillus-Calmette-Guerin vaccination. J. Immunol. 163:2249-2255.
29. Marodi, L. 2002. Down-regulation of Th1 responses in human neonates. Clin. Exp. Immunol. 128:1-2.
30. Mascart, F., M. Hainaut, A. Peltier, V. Verscheure, J. Levy, and C. Locht. 2007. Modulation of the infant immune responses by the first pertussis vaccine administrations. Vaccine 25:391-398. (Pubitemid 44873143)
31. Menozzi, F. D., R. Mutombo, G. Renauld, C. Gantiez, J. H. Hannah, E. Leininger, M. J. Brennan, and C. Locht. 1994. Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. Infect. Immun. 62:769-778.
32. Mielcarek, N., A.-S. Debrie, D. Raze, J. Bertout, C. Rouanet, A. B. Younes, C. Creusy, J. Engle, W. E. Goldman, and C. Locht. 2006. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog. 2:e65.
33. Mielcarek, N., A.-S. Debrie, D. Raze, J. Quatannens, J. Engle, W. E. Goldman, and C. Locht. 2006. Attenuated Bordetella pertussis: new live vaccines for intranasal immunisation. Vaccine 24:S54-S55.
34. Mills, K. H., A. Barnard, J. Watkins, and K. Redhead. 1993. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect. Immun. 61:399-410.
35. Mills, K. H. G., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
36. Muller, U., S. Reis, J. Hemmi, R. Pavloviv, R. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science 262:1918-1921. (Pubitemid 24245635)
37. Prescott, S. L., C. Macaubas, B. J. Holt, T. B. Smallacombe, R. Loh, and P. D. Sly. 1998. Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward Th2 cytokine profile. J. Immunol. 160:4730-4737.
38. Salmaso, S., P. Mastrantonio, S. G. F. Wassilak, M. Giuliano, A. Anemona, A. Giammanco, A. E. Tozzi, M. L. Ciofi degli Atti, and D. Greco. 1998. Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Vaccine 16:1270-1275.
39. Snapper, C. M., F. D. Finkelman, and W. E. Paul. 1988. Regulation of IgG1 and IgE production by interleukin 4. Immunol. Rev. 102:51-75.
40. Trøseid, M., T. Ø. Jonassen, and M. Steinbakk. 2006. Isolation of Bordetella pertussis in blood culture from a patient with multiple myeloma. J. Infect. 52:e11-e13.
41. von König, C. H., S. Halperin, M. Riffelmann, and N. Guiso. 2002. Pertussis of adults and infants. Lancet Infect. Dis. 2:744-750.
42. Weiss, A. A., and M. S. Goodwin. 1989. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect. Immun. 57:3757-3764.
43. Wolfe, D. N., E. M. Goebel, O. N. Bjornstad, O. Restif, and E. T. Harvill. 2007. The O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunity. Infect. Immun. 75:4972-4979.
44. Wolfe, D. N., P. B. Mann, A. M. Buboltz, and E. T. Harvill. 2007. Delayed role of tumor necrosis factor-alpha in overcoming the effects of pertussis toxin. J. Infect. Dis. 196:1228-1236.
45. Zachariadis, O., J. Cassidy, C. Brady, and B. P. Mahon. 2006. γδ T cells regulate the early inflammatory response to Bordetella pertussis infection in the murine respiratory tract. Infect. Immun. 74:1837-1845.